Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press1305610.36691/RJA13056Clinical practice guidelinesКлинические рекомендацииReview ArticlePractical issues of using emollients for the prevention of exacerbations of atopic dermatitis during the flowering season: Expert resolutionПрактические вопросы применения эмолентов с целью профилактики обострений атопического дерматита в сезон цветения: резолюция экспертовhttps://orcid.org/0000-0003-3358-50875012-7242FedenkoElena S.ФеденкоЕлена Сергеевна
Russian Federation

MD, Dr. Sci. (Med), Professor

д-р мед. наук, профессор

efedks@gmail.comhttps://orcid.org/0000-0003-4200-45984357-3897ZakharovaIrina N.ЗахароваИрина Николаевна
Russian Federation

MD, Dr. Sci. (Med), Professor

д-р мед. наук, профессор

kafedra25@yandex.ruhttps://orcid.org/0000-0003-3426-34263090-4876ZaytsevaOlga V.ЗайцеваОльга Витальевна
Russian Federation

MD, Dr. Sci. (Med), Professor

д-р мед. наук, профессор

olga6505963@yandex.ruhttps://orcid.org/0000-0001-5039-84739722-7961PampuraAlexander N.ПампураАлександр Николаевич
Russian Federation

MD, Dr. Sci. (Med), Professor

д-р мед. наук, профессор

apampura@pedklin.ruhttps://orcid.org/0000-0003-3261-67185476-8497TamrazovaOlga B.ТамразоваОльга Борисовна
Russian Federation

MD, Dr. Sci. (Med), Professor

д-р мед. наук, профессор

anait_tamrazova@mail.ruNational Research Center ― Institute of ImmunologyГосударственный научный центр «Институт иммунологии»Russian Medical Academy of Continuous Professional EducationРоссийская медицинская академия непрерывного профессионального образованияMoscow State University of Medicine and Dentistry named after A.I. EvdokimovМосковский государственный медико-стоматологический университет имени А.И. ЕвдокимоваVeltischev Research and Clinical Institute for Pediatrics and Pediatric SurgeryНаучно-исследовательский клинический институт педиатрии и детской хирургии имени академика Ю.Е. ВельтищеваPeoples’ Friendship University of RussiaРоссийский университет дружбы народов имени Патриса Лумумбы27062023090720232021201291906202321062023Copyright ©; 2023, Pharmarus Print MediaCopyright ©; 2023, Фармарус Принт Медиа2023Pharmarus Print MediaФармарус Принт Медиаhttps://creativecommons.org/licenses/by-nc-nd/4.0/https://rusalljournal.ru/raj/article/view/13056

In February 2023, a meeting of the Council of Experts was held, attended by leading specialists in the fields of allergology, pediatrics and dermatology.

The Working Group discussed the problem of sensitization to pollen allergens in patients with atopic dermatitis and exacerbation of the disease during the pollination season of plants, as well as the formation of epicutaneous sensitization through a damaged epidermal barrier. The experts comprehensively considered the criteria that a modern emollient used for the care of atopic dermatitis patients' skin should meet, discussed the role of moisturizers in preventing seasonal exacerbations of atopic dermatitis based on previously conducted research, and developed unified recommendations on the principles of managing this type of patients.

Suggestions were made for further informational and organizational measures aimed at expanding the knowledge of patients and medical specialists about the problem of epicutaneous sensitization to aeroallergens in atopic dermatitis patients, their role in the development of seasonal exacerbations of atopic dermatitis, and the possibility of their prevention using modern emollients.

В феврале 2023 года состоялось совещание Совета экспертов, в котором приняли участие ведущие специалисты в области аллергологии, педиатрии и дерматовенерологии.

Рабочая группа обсудила проблемы сенсибилизации к пыльцевым аллергенам у пациентов с атопическим дерматитом и обострения заболевания в период цветения растений, а также формирования чрескожной сенсибилизации через повреждённый эпидермальный барьер. Эксперты комплексно рассмотрели критерии, которым должен отвечать современный эмолент, применяемый для ухода за кожей больных атопическим дерматитом; обсудили роль увлажняющих средств в профилактике сезонных обострений атопического дерматита на основании проведённого ранее исследования и выработали единые рекомендации о принципах ведения таких пациентов.

Высказаны предложения о дальнейших информационных и организационных мероприятиях, направленных на расширение знаний пациентов и врачей о проблеме чрескожной сенсибилизации к аэроаллергенам у больных атопическим дерматитом, их роли в развитии сезонных обострений и возможности их профилактики с использованием современных эмолентов.

atopic dermatitisemollientsepidermal barrierpollen allergycutaneous sensitizationатопический дерматитэмолентыэпидермальный барьерпыльцевая аллергиячрескожная сенсибилизацияThe Expert Council was organized with the support of La Roche Posay company. Employees of La Roche Posay had the opportunity to review the resolution text prior to publication and provide comments regarding the company’s products. However, all decisions regarding the final text were made by the publication authors.Совет экспертов был организован при поддержке компании La Roche Posay. Сотрудники компании La Roche Posay имели возможность ознакомиться с текстом резолюции до публикации и оставить комментарии касательно продукции компании, тем не менее все решения по финальному тексту принимали авторы публикации.Federal clinical guidelines for the management of patients with atopic dermatitis. Moscow: Russian Society of Dermatovenerologists and Cosmetologists, Russian Association of Allergologist and Clinical Immunologist, Union of Pediatricians of Russia, National Alliance of Dermatovenerologists and Cosmetologists; 2021. Available from: https://cr.minzdrav.gov.ru/recomend/265_2 Accessed: 28.05.2023.Federal clinical guidelines for the management of patients with atopic dermatitis. Moscow: Russian Society of Dermatovenerologists and Cosmetologists, Russian Association of Allergologist and Clinical Immunologist, Union of Pediatricians of Russia, National Alliance of Dermatovenerologists and Cosmetologists, 2021. Режим доступа: https://cr.minzdrav.gov.ru/recomend/265_2. Дата обращения: 28.05.2023.Nutten S. Atopic dermatitis: Global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16. doi: 10.1159/000370220Nutten S. Atopic dermatitis: Global epidemiology and risk factors // Ann Nutr Metab. 2015. Vol. 66, Suppl. 1. Р. 8–16. doi: 10.1159/000370220Lewis-Jones S. Quality of life and childhood atopic dermatitis: The misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–992. doi: 10.1111/j.1742-1241.2006.01047.xLewis-Jones S. Quality of life and childhood atopic dermatitis: The misery of living with childhood eczema // Int J Clin Pract. 2006. Vol. 60, N 8. Р. 984–992. doi: 10.1111/j.1742-1241.2006.01047.xLiang Y, Chang C, Lu Q. The genetics and epigenetics of atopic dermatitis-filaggrin and other polymorphisms. Clin Rev Allergy Immunol. 2016;51(3):315–328. doi: 10.1007/s12016-015-8508-5Liang Y., Chang C., Lu Q. The genetics and epigenetics of atopic dermatitis-filaggrin and other polymorphisms // Clin Rev Allergy Immunol. 2016. Vol. 51, N 3. Р. 315–328. doi: 10.1007/s12016-015-8508-5Birben E, Sackesen C, Turgutoğlu N, Kalayci O. The role of SPINK5 in asthma related physiological events in the airway epithelium. Respir Med. 2012;106(3):349–355. doi: 10.1016/j.rmed.2011.11.007Birben E., Sackesen C., Turgutoğlu N., Kalayci O. The role of SPINK5 in asthma related physiological events in the airway epithelium // Respir Med. 2012. Vol. 106, N 3. Р. 349–355. doi: 10.1016/j.rmed.2011.11.007Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. doi: 10.1016/j.alit.2017.10.002Egawa G., Kabashima K. Barrier dysfunction in the skin allergy // Allergol Int. 2018. Vol. 67, N 1. Р. 3–11. doi: 10.1016/j.alit.2017.10.002Ständer S. Atopic Dermatitis. N Engl J Med. 2021;384(12): 1136–1143. doi: 10.1056/NEJMra2023911Ständer S. Atopic Dermatitis // N Engl J Med. 2021. Vol. 384, N 12. Р. 1136–1143. doi: 10.1056/NEJMra2023911Li H, Zhang Z, Zhang H, et al. Update on the pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324–338. doi: 10.1007/s12016-021-08880-3Li H., Zhang Z., Zhang H., et al. Update on the pathogenesis and therapy of atopic dermatitis // Clin Rev Allergy Immunol. 2021. Vol. 61, N 3. Р. 324–338. doi: 10.1007/s12016-021-08880-3Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26. doi: 10.1080/1744666X.2016.1212660Kantor R., Silverberg J.I. Environmental risk factors and their role in the management of atopic dermatitis // Expert Rev Clin Immunol. 2017. Vol. 13, N 1. Р. 15–26. doi: 10.1080/1744666X.2016.1212660Hostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3(1):22–31.Hostetler S.G., Kaffenberger B., Hostetler T., Zirwas M.J. The role of airborne proteins in atopic dermatitis // J Clin Aesthet Dermatol. 2010. Vol. 3, N 1. Р. 22–31.Serhan N, Basso L, Sibilano R, et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol. 2019;20(11):1435–1443. doi: 10.1038/s41590-019-0493-zSerhan N., Basso L., Sibilano R., et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation // Nat Immunol. 2019. Vol. 20, N 11. Р. 1435–1443. doi: 10.1038/s41590-019-0493-zHostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3(1):22–31.Hostetler S.G., Kaffenberger B., Hostetler T., Zirwas M.J. The role of airborne proteins in atopic dermatitis // J Clin Aesthet Dermatol. 2010. Vol. 3, N 1. Р. 22–31.Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96–103.e9. doi: 10.1016/j.jaci.2015.04.015Werfel T., Heratizadeh A., Niebuhr M., et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber // J Allergy Clin Immunol. 2015. Vol. 136, N 1. Р. 96–103.e9. doi: 10.1016/j.jaci.2015.04.015Fölster-Holst R, Galecka J, Weißmantel S, et al. Birch pollen influence the severity of atopic eczema: Prospective clinical cohort pilot study and ex vivo penetration study. Clin Cosmet Investig Dermatol. 2015;(8):539–548. doi: 10.2147/CCID.S81700Fölster-Holst R., Galecka J., Weißmantel S., et al. Birch pollen influence the severity of atopic eczema: Prospective clinical cohort pilot study and ex vivo penetration study // Clin Cosmet Investig Dermatol. 2015. N 8. Р. 539–548. doi: 10.2147/CCID.S81700Knaysi G, Smith AR, Wilson JM, Wisniewski JA. The skin as a route of allergen exposure: Part II. Allergens and role of the microbiome and environmental exposures. Curr Allergy Asthma Rep. 2017;17(1):7. doi: 10.1007/s11882-017-0675-4Knaysi G., Smith A.R., Wilson J.M., Wisniewski J.A. The skin as a route of allergen exposure: Part II. Allergens and role of the microbiome and environmental exposures // Curr Allergy Asthma Rep. 2017. Vol. 17, N 1. Р. 7. doi: 10.1007/s11882-017-0675-4Brough HA, Nadeau KC, Sindher SB, et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? Allergy. 2020;75(9):2185–2205. doi: 10.1111/all.14304Brough H.A., Nadeau K.C., Sindher S.B., et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? // Allergy. 2020. Vol. 75, N 9. Р. 2185–2205. doi: 10.1111/all.14304Strid J, Hourihane J, Kimber I, et al. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol. 2004;34(8):2100–2109. doi: 10.1002/eji.200425196Strid J., Hourihane J., Kimber I., et al. Disruption of the stratum corneum allows potent percutaneous immunization with protein antigens resulting in a dominant systemic Th2 response // Eur J Immunol. 2004. Vol. 34, N 8. Р. 2100–2109. doi: 10.1002/eji.200425196Brough HA, Nadeau KC, Sindher SB, et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? Allergy. 2020;75(9):2185–2205. doi: 10.1111/all.14304Brough H.A., Nadeau K.C., Sindher S.B., et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? // Allergy. 2020. Vol. 75, N 9. Р. 2185–2205. doi: 10.1111/all.14304Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680. doi: 10.1038/ni805Soumelis V., Reche P.A., Kanzler H., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP // Nat Immunol. 2002. Vol. 3, N 7. Р. 673–680. doi: 10.1038/ni805Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol. 2010;126(5):976–984.e9845. doi: 10.1016/j.jaci.2010.08.041Oyoshi M.K., Larson R.P., Ziegler S.F., Geha R.S. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression // J Allergy Clin Immunol. 2010. Vol. 126, N 5. Р. 976–984.e9845. doi: 10.1016/j.jaci.2010.08.041Tordesillas L, Goswami R, Benedé S, et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest. 2014;124(11):4965–4975. doi: 10.1172/JCI75660Tordesillas L., Goswami R., Benedé S., et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens // J Clin Invest. 2014. Vol. 124, N 11. Р. 4965–4975. doi: 10.1172/JCI75660Komai-Koma M, Brombacher F, Pushparaj PN, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy. 2012;67(9):1118–1126. doi: 10.1111/j.1398-9995.2012.02859.xKomai-Koma M., Brombacher F., Pushparaj P.N., et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice // Allergy. 2012. Vol. 67, N 9. Р. 1118–1126. doi: 10.1111/j.1398-9995.2012.02859.xWassmann-Otto A, Heratizadeh A, Wichmann K, Werfel T. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy. 2018;73(10):2046–2054. doi: 10.1111/all.13454Wassmann-Otto A., Heratizadeh A., Wichmann K., Werfel T. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis // Allergy. 2018. Vol. 73, N 10. Р. 2046–2054. doi: 10.1111/all.13454Reekers R, Busche M, Wittmann M, et al. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104(2 Pt 1):466–472. doi: 10.1016/s0091-6749(99)70395-7Reekers R., Busche M., Wittmann M., et al. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens // J Allergy Clin Immunol. 1999. Vol. 104, N 2, Pt. 1. Р. 466–472. doi: 10.1016/s0091-6749(99)70395-7De Bruin-Weller M, Gadkari A, Auziere S, et al. The patient-reported disease burden in adults with atopic dermatitis: A cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34(5):1026–1036. doi: 10.1111/jdv.16003De Bruin-Weller M., Gadkari A., Auziere S., et al. The patient-reported disease burden in adults with atopic dermatitis: A cross-sectional study in Europe and Canada // J Eur Acad Dermatol Venereol. 2020. Vol. 34, N 5. Р. 1026–1036. doi: 10.1111/jdv.16003Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. doi: 10.1111/jdv.14891Wollenberg A., Barbarot S., Bieber T., et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part I // J Eur Acad Dermatol Venereol. 2018. Vol. 32, N 5. Р. 657–682. doi: 10.1111/jdv.14891Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. doi: 10.1016/j.jaad.2014.03.023Eichenfield L.F., Tom W.L., Berger T.G., et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies // J Am Acad Dermatol. 2014. Vol. 71, N 1. Р. 116–132. doi: 10.1016/j.jaad.2014.03.023Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–1060. doi: 10.1111/j.1468-3083.2012.04635.xRing J., Alomar A., Bieber T., et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part I // J Eur Acad Dermatol Venereol. 2012. Vol. 26, N 8. Р. 1045–1060. doi: 10.1111/j.1468-3083.2012.04635.xGiménez-Arnau A. Standards for the protection of skin barrier function. Curr Probl Dermatol. 2016;(49):123–134. doi: 10.1159/000441588Giménez-Arnau A. Standards for the protection of skin barrier function // Curr Probl Dermatol. 2016. N 49. Р. 123–134. doi: 10.1159/000441588Guéniche A, Dahel K, Bastien P, et al. Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms. J Eur Acad Dermatol Venereol. 2008;22(6): 746–747. doi: 10.1111/j.1468-3083.2007.02428.xGuéniche A., Dahel K., Bastien P., et al. Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms // J Eur Acad Dermatol Venereol. 2008. Vol. 22, N 6. Р. 746–747. doi: 10.1111/j.1468-3083.2007.02428.xGueniche A, Knaudt B, Schuck E, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159(6):1357–1363. doi: 10.1111/j.1365-2133.2008.08836.xGueniche A., Knaudt B., Schuck E., et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled clinical study // Br J Dermatol. 2008. Vol. 159, N 6. Р. 1357–1363. doi: 10.1111/j.1365-2133.2008.08836.xMainzer C, Le Guillou M, Vyumvuhore R, et al. Clinical efficacy of oligofructans from ophiopogon japonicus in reducing atopic dermatitis flare-ups in caucasian patients. Acta Derm Venereol. 2019;99(10):858–864. doi: 10.2340/00015555-3224Mainzer C., Le Guillou M., Vyumvuhore R., et al. Clinical efficacy of oligofructans from ophiopogon Japonicas in reducing atopic dermatitis flare-ups in Caucasian patients // Acta Derm Venereol. 2019. Vol. 99, N 10. Р. 858–864. doi: 10.2340/00015555-3224Meinke MC, Patzelt A, Richter H, et al. Prevention of follicular penetration: Barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Skin Pharmacol Physiol. 2011;24(3):144–150. doi: 10.1159/000323018Meinke M.C., Patzelt A., Richter H., et al. Prevention of follicular penetration: Barrier-enhancing formulations against the penetration of pollen allergens into hair follicles // Skin Pharmacol Physiol. 2011. Vol. 24, N 3. Р. 144–150. doi: 10.1159/000323018Lademann J, Patzelt A, Richter H, et al. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions. Eur J Pharm Biopharm. 2009;72(3):600–604. doi: 10.1016/j.ejpb.2009.02.003Lademann J., Patzelt A., Richter H., et al. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions // Eur J Pharm Biopharm. 2009. Vol. 72, N 3. Р. 600–604. doi: 10.1016/j.ejpb.2009.02.003Billmann-Eberwein C, Rippke F, Ruzicka T, et al. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient. Skin Pharmacol Appl Skin Physiol. 2002;15(2):100–104. doi: 10.1159/000049396Billmann-Eberwein C., Rippke F., Ruzicka T., et al. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient // Skin Pharmacol Appl Skin Physiol. 2002. Vol. 15, N 2. Р. 100–104. doi: 10.1159/000049396Litovkina AO, Smolnikov EV, Elisyutina OG, Fedenko ES. The role of modern emollients in prophylaxis of atopic dermatitis exacerbation during pollination season. Russ J Allergy. 2023;20(1):41–51. (In Russ). doi: 10.36691/RJA4136Литовкина А.О., Смольников Е.В., Елисютина О.Г., Феденко Е.С. Современные эмоленты в профилактике обострений атопического дерматита в сезон цветения // Российский аллергологический журнал. 2023. Т. 20, № 1. С. 41–51. doi: 10.36691/RJA4136Luger T, Amagai M, Dreno B, et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci. 2021;102(3):142–157. doi: 10.1016/j.jdermsci.2021.04.007Luger T., Amagai M., Dreno B., et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents // J Dermatol Sci. 2021. Vol. 102, N 3. Р. 142–157. doi: 10.1016/j.jdermsci.2021.04.007Lowe AJ, Su JC, Allen KJ, et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: The PEBBLES pilot study. Br J Dermatol. 2018;178(1):e19–e21. doi: 10.1111/bjd.15747Lowe A.J., Su J.C., Allen K.J., et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: The PEBBLES pilot study // Br J Dermatol. 2018. Vol. 178, N 1. Р. e19–e21. doi: 10.1111/bjd.15747